Unilabs News
Unilabs appoints Jourik Hooghe as Chief Financial Officer
Geneva, 28 April – Unilabs, one of the leading providers of medical diagnostic services in Europe, today announced the appointment of Jourik Hooghe as Chief Financial Officer, effective 1 May 2026.
Jourik joins Unilabs from Swissport, where he served as Group CFO. He brings extensive international leadership experience, having previously served as EVP and Group CFO at Wizz Air and held global roles at the Adecco Group and Procter & Gamble, where he spent 18 years across Europe, Asia, and the United States.
With a strong track record in driving financial performance and turnarounds, scaling complex platforms, and delivering transformation and value‑creation initiatives across both listed and private equity environments, Jourik brings a broad set of capabilities that will support Unilabs’ strategy and ambitions.
In his new role, Jourik will help further strengthen Unilabs’ operational and financial foundations and play a key part in guiding the company through its next phase of growth.
Badhri Srinivasan, Group Chief Executive Officer, Unilabs, commented:
“We are delighted to welcome Jourik to Unilabs. His international finance expertise, proven ability to lead in complex organisations, and disciplined, long‑term approach will support the continued execution of our strategy and the strengthening of our financial and operational foundations.”
Jourik Hooghe, incoming Chief Financial Officer, Unilabs
“Unilabs plays an important role in delivering trusted diagnostics. I look forward to contributing my experience to support the company’s strategy, strengthen performance, and build long‑term value.”
As Chief Financial Officer, Jourik succeeds Carsten Højlund.
About Unilabs
Unilabs is one of the leading providers of diagnostic services in Europe, offering a complete range of laboratory, pathology, genetics and imaging services to patients across four continents.
With over 13,000 employees, 1,300 laboratories and over 2,100 sample collection points, the company treats around 250 million patients annually, performs 237 million laboratory tests and 6 million imaging examinations and analyzes 9 million pathology sections. In this way, Unilabs helps hundreds of millions of patients and their doctors to make informed decisions.
For more information visit www.unilabs.com
Media contact: